(Q39068040)

8 September 2017

title

Review: Tau in biofluids - relation to pathology, imaging and clinical features (English)

1 reference

8 September 2017

0 references

H Zetterberg

1

1 reference

8 September 2017

publication date

5 January 2017

1 reference

Neuropathology and Applied Neurobiology

8 September 2017

published in

1 reference

8 September 2017

volume

43

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

194-199

1 reference

Amyloid plaque core protein in Alzheimer disease and Down syndrome

8 September 2017

cites work

1 reference

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

21 January 2018

1 reference

One of the antigenic determinants of paired helical filaments is related to tau protein

21 January 2018

1 reference

Tau: From research to clinical development

21 January 2018

1 reference

Biochemistry and cell biology of tau protein in neurofibrillary degeneration

21 January 2018

1 reference

Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease

21 January 2018

1 reference

Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein

21 January 2018

1 reference

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

21 January 2018

1 reference

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

21 January 2018

1 reference

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

21 January 2018

1 reference

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke

21 January 2018

1 reference

Neurochemical aftermath of amateur boxing

21 January 2018

1 reference

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

21 January 2018

1 reference

Converging molecular pathways in human neural development and degeneration

21 January 2018

1 reference

Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections

21 January 2018

1 reference

Hyperphosphorylation of tau protein in superficial CNS siderosis

21 January 2018

1 reference

CSF tau protein is a useful marker for effective treatment of superficial siderosis of the central nervous system: two case reports.

21 January 2018

1 reference

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

21 January 2018

1 reference

CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings

21 January 2018

1 reference

Cerebrospinal fluid proteins predict longitudinal hippocampal degeneration in early-stage dementia of the Alzheimer type

21 January 2018

1 reference

Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly

21 January 2018

1 reference

Distribution of tau proteins in the normal human central and peripheral nervous system

21 January 2018

1 reference

Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.

21 January 2018

1 reference

A presenilin-1 Thr116Asn substitution in a family with early-onset Alzheimer's disease

21 January 2018

1 reference

Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype

21 January 2018

1 reference

CSF biomarkers predict a more malignant outcome in Alzheimer disease.

21 January 2018

1 reference

Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry

21 January 2018

1 reference

Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study

21 January 2018

1 reference

Plasma tau levels in Alzheimer's disease

21 January 2018

1 reference

Blood biomarkers for brain injury in concussed professional ice hockey players.

21 January 2018

1 reference

Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury

21 January 2018

1 reference

Peripheral Total Tau in Military Personnel Who Sustain Traumatic Brain Injuries During Deployment

21 January 2018

1 reference

21 January 2018

1 reference

Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease

21 January 2018

1 reference

Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies

21 January 2018

1 reference

Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization

21 January 2018

1 reference

Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates

21 January 2018

1 reference

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.

21 January 2018

1 reference

Quantification of tau in cerebrospinal fluid by immunoaffinity enrichment and tandem mass spectrometry.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/NAN.12378

1 reference

8 September 2017

1 reference